10-year outcome of childhood epilepsy in well-functioning children and adolescents

Pysse Jonsson1, Orvar Eeg-Olofsson

  • 1Department of Women's and Children's Health/Neuropaediatrics, Uppsala University, Uppsala, Sweden.

Insights

Most children with epilepsy who were well-functioning in 1997 achieved remission after 10 years. Focal seizures were common, with Rolandic epilepsy being the most frequent diagnosis in this pediatric epilepsy cohort.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Epidemiology
  • Clinical Outcomes

Background:

  • A population-based study identified children with epilepsy in a Swedish county.
  • This study focused on a subset of well-functioning individuals from the original cohort.

Purpose of the Study:

  • To describe the 10-year medical outcome for well-functioning children with epilepsy.
  • To analyze seizure types, epilepsy syndromes, and treatment in this cohort.
  • To investigate individual and family history in relation to epilepsy outcomes.

Main Methods:

  • A questionnaire was administered to 45 individuals (aged 11-21) and their parents.
  • Hospital records were reviewed for detailed medical information.
  • A 10-year follow-up period was assessed from January 1997.

Main Results:

  • 75.6% of patients achieved remission after 10 years.
  • Focal seizures were prevalent (57.8%), with Rolandic epilepsy diagnosed in 33.3%.
  • Family history of epilepsy (44.4%) and primary headache (57.8%) were common.

Conclusions:

  • Longitudinal studies are crucial for understanding epilepsy epidemiology.
  • The findings highlight the positive outcomes for well-functioning children with epilepsy.
  • Epilepsy phenotypes and family history may influence outcomes.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...